Richard Morris - 31 Jan 2024 Form 4 Insider Report for Carisma Therapeutics Inc. (CARM)

Role
Chief Financial Officer
Signature
/s/ Richard Morris
Issuer symbol
CARM
Transactions as of
31 Jan 2024
Transactions value $
$0
Form type
4
Filing time
02 Feb 2024, 16:53:46 UTC
Previous filing
08 Jun 2023
Next filing
18 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARM Stock Option (Right to Buy) Award $0 +171K $0.00 171K 31 Jan 2024 Common Stock 171K $2.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.